AstraZeneca's top-selling cancer drug sees early unblinding in key trial
Reuters
URL: https://www.reuters.com/article/us-astr ... SKCN21S22D
Category: healthNews
Published: Fri, 10 Apr 2020 16:48:49 -0400
Description: AstraZeneca Plc said the third phase trial of its top-selling cancer drug Tagrisso, aimed at showing the drug's benefit in lung cancer treatment, will be unblinded early after a recommendation from an independent data monitoring committee.